Prediction of left ventricular reverse remodeling after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy

Documenti analoghi

• Clinical Features of the Dilated Phase of Hypertrophic Cardiomyopathy in Comparison With Those of Dilated Cardiomyopathy
  di: Hamada, Tomoyuki, et al.
  Pubblicazione: (2010)
• Serum Cardiac Troponin I is Related to Increased Left Ventricular Wall Thickness, Left Ventricular Dysfunction, and Male Gender in Hypertrophic Cardiomyopathy
  di: Kubo, Toru, et al.
  Pubblicazione: (2009)
• Giant Left Atrial Myxoma in a Nonagenarian
  di: Matsumura, Yoshihisa, et al.
  Pubblicazione: (2013)
• The appropriate dose of angiotensin‐converting‐enzyme inhibitors or angiotensin receptor blockers in patients with dilated cardiomyopathy. The higher, the better?
  di: Ishida, Junichi, et al.
  Pubblicazione: (2015)
• A Novel Disease Entity in Search of Its Own Identity　― Takotsubo Syndrome. Is It Really “Cardiomyopathy”? ―
  di: Doi, Yoshinori L., et al.
  Pubblicazione: (2020)